HIND - NASDAQ

Vyome Holdings, Inc.

HIND·NASDAQ

$5.73

+14%

HealthcareBiotechnology

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$151.09M

EPS-345.7400

P/E Ratio-1.29

Earnings Date05/18/2026

hind

Other Current Liabilities

Last Annual Value

1.82M

3-Year CAGR

78%

5-Year CAGR

-10%

10-Year CAGR

Adjust for Inflation

Vyome Holdings, Inc. Competitors Analysis of Other Current Liabilities

HIND · NASDAQ

Company	Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Vyome Holdings, Inc. NASDAQ:HIND	1.82M	15.9%	41.5%	N/A
Armata Pharmaceuticals, Inc. AMEX:ARMP	3.46M	38.9%	N/A	15.4%
Codexis, Inc. NASDAQ:CDXS	13.81M	7.1%	4.4%	30.8%
Nuvectis Pharma, Inc. NASDAQ:NVCT	7.02M	22.7%	118.2%	N/A
Sangamo Therapeutics, Inc. NASDAQ:SGMO	25.43M	29.4%	4.1%	22.3%
Tonix Pharmaceuticals Holding Corp. NASDAQ:TNXP	22.60M	63.8%	58.7%	N/A
C4 Therapeutics, Inc. NASDAQ:CCCC	13.31M	12.4%	19.4%	N/A
Acumen Pharmaceuticals, Inc. NASDAQ:ABOS	20.54M	73.9%	47.3%	N/A
Anixa Biosciences, Inc. NASDAQ:ANIX	922.00K	N/A	N/A	N/A
Atossa Therapeutics, Inc. NASDAQ:ATOS	3.96M	30.0%	29.3%	46.2%
Greenwich LifeSciences, Inc. NASDAQ:GLSI	0.00	N/A	N/A	N/A

Vyome Holdings, Inc. Fair Value Envelope

HIND · NASDAQ

Our analysis suggests that HIND has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.73, this represents a potential HIDDEN relative to our calculated worth for Vyome Holdings, Inc..

HIDDEN

Intrinsic Value

Current Price: $5.73

Related Guides

Blog Categories

Continue your HIND research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.